What do PCOS (Polycystic Ovary Syndrome) labs typically show?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Findings in Polycystic Ovary Syndrome (PCOS)

PCOS laboratory tests typically show elevated total testosterone as the most common abnormality, present in 70% of cases, along with an elevated LH/FSH ratio, low progesterone, and markers of insulin resistance. 1

Key Laboratory Abnormalities in PCOS

Hormonal Profile

  • Total testosterone: Elevated in 70% of PCOS cases (>2.5 nmol/L) - most frequently abnormal marker 1, 2
  • LH/FSH ratio: Often elevated (>2), but only abnormal in 41-44% of cases 1, 2
  • Free Androgen Index (FAI): 78% sensitivity, 85% specificity 1
  • Androstenedione (A4): Elevated in 53% of cases, with 75% sensitivity, 71% specificity 1, 2
  • Dehydroepiandrosterone sulfate (DHEAS): 75% sensitivity, 67% specificity 1
  • Calculated bioavailable testosterone: 76% sensitivity, 83% specificity (cutoff of 0.78 nmol/L) 1
  • Progesterone: Often low (<6 nmol/L) indicating anovulation 1

Metabolic Parameters

  • Glucose/insulin ratio: Often abnormal (<4), indicating insulin resistance 1
  • Fasting insulin: May be elevated 3
  • Glucose tolerance: May show impaired glucose tolerance or insulin resistance 3

First-Line Laboratory Tests for PCOS Diagnosis

The Endocrine Society recommends the following first-line tests 1:

  • Total testosterone
  • Free testosterone
  • Thyroid-stimulating hormone (TSH)
  • Prolactin
  • 17-hydroxyprogesterone

Diagnostic Considerations

Diagnostic Accuracy

  • Best single hormonal marker: Total testosterone (70% sensitivity) 2
  • Best combination: Testosterone, androstenedione, and LH (abnormal in 86% of PCOS cases) 2
  • Caution with LH/FSH ratio: Despite historical emphasis, this has low sensitivity and should not be used as the sole diagnostic criterion 2

Ultrasonographic Correlation

Laboratory findings should be correlated with ultrasonographic features, which may include:

  • Increased follicle number per ovary (FNPO) - most accurate diagnostic marker (84% sensitivity, 91% specificity) 4
  • Increased ovarian volume (OV) (81% sensitivity, 81% specificity) 4
  • Increased follicle number per single cross-section (FNPS) (81% sensitivity, 83% specificity) 4

Common Pitfalls and Caveats

  1. Assay variability: Different assays for the same hormone can yield significantly different results, particularly for LH and FSH 2

  2. Timing of tests: Hormonal measurements should ideally be taken in the early follicular phase (days 2-5) of the menstrual cycle in women who are menstruating 2

  3. SHBG considerations: Sex hormone-binding globulin levels are often influenced by body mass index, showing a negative correlation with BMI in women with PCOS 2

  4. Anti-Müllerian Hormone (AMH): While not yet standardized for routine clinical use, AMH is typically elevated in PCOS and may eventually replace ultrasound for PCOM detection once standardization issues are resolved 4

  5. Adolescent testing: Laboratory interpretation may differ in adolescents, as normal ranges can overlap with PCOS values in this age group 4

Differential Diagnosis Considerations

When interpreting laboratory results, consider other conditions that may present with similar findings:

  • Functional hypothalamic amenorrhea: Typically has LH/FSH ratio <1 in 82% of cases, unlike PCOS 1
  • Thyroid disorders: Abnormal TSH should prompt further thyroid evaluation
  • Hyperprolactinemia: Elevated prolactin may indicate pituitary disorders rather than PCOS
  • Congenital adrenal hyperplasia: Elevated 17-hydroxyprogesterone may indicate this condition rather than PCOS

By combining clinical features, laboratory findings, and ultrasonographic evaluation, a comprehensive assessment for PCOS can be achieved, with total testosterone being the most reliable single laboratory marker.

References

Guideline

Reproductive Endocrinology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Which hormone tests for the diagnosis of polycystic ovary syndrome?

British journal of obstetrics and gynaecology, 1992

Research

Hormonal changes in PCOS.

The Journal of endocrinology, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.